Zydus Pharmaceuticals (USA) Inc recalls Erythromycin Tablets
- Published
- 27 May 2026
- Units affected
- 2 products
- Agency
- FDA
- Country
- United States
The hazard
CGMP Deviations; presence of N-Nitroso-Desmethyl-Erythromycin above the recommended acceptable intake limit
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Erythromycin Tablets, USP, 500 mg, 30 tablets per bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534; (NDC 70710-1048-3).
Erythromycin Tablets, USP, 250 mg, 30 tablets per bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534; a) 30 count bottles (NDC 70710-1047-3); b) 100 count bottles (NDC 70710-1047-1).
- Brand / company
- Zydus Pharmaceuticals (USA) Inc
- Codes / lots
- Lots: a) M411147, Expires: 08/2026; M502100, M502099, Expires: 01/2027. | Lots: a) M411146, Expires: 08/2026; M502098, M502097, Expires: 01/2027; b) M411145, Expires: 08/2026.
- Distribution
- Nationwide within the U.S
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 27 May 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.